acrolein has been researched along with Atherogenesis in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, K; Kashiwagi, K | 1 |
| Brown, J; Cicalo, C; Crowley, LN; Han, BK; Kim, JK; Kim, YJ; Le, BL; Lee, JH; Lennon, SL; Li, Y; Pan, JH | 1 |
| Abdel-Reheim, ES; Ali, TM; Elesawy, BH; Ismail, BS; Mahmoud, B; Soliman, HA; Zaky, MY | 1 |
| Dragon, J; Knura, M; Okopień, B; Łabuzek, K | 1 |
| Chen, A; Feng, Q; Haq, IU; Jiang, P; Li, C; Mariyam, Z; Wu, X; Zeb, F; Zhou, M | 1 |
| El-Awady, MS; Nour, OAA; Rahim, MA; Shehatou, GSG; Suddek, GM | 1 |
| Aiuchi, T; Hayashi, M; Itabe, H; Kato, R; Obama, T; Sawada, N | 1 |
| Hayes, AW; Karimani, A; Karimi, G; Mehri, S; Zeinali, M; Zirak, MR | 1 |
| Li, W; Liu, F; Niu, X; Zang, L; Zhao, J; Zhi, W | 1 |
| Chen, A; Chen, L; Feng, Q; Haq, IU; Jiang, P; Li, C; Wu, X; Xu, C; Zeb, F | 1 |
| Aviram, M; Bar, H; Danin-Poleg, Y; Hayek, T; Kashi, Y; Korach-Rechtman, H; Rom, O | 1 |
| Barski, O; Bhatnagar, A; Conklin, DJ; Hellmann, J; O'Toole, TE; Zheng, YT | 1 |
| Bhatnagar, A; Conklin, DJ; D'Souza, SE; Haberzettl, P; Hoetker, DJ; Siddiqui, MA; Sithu, SD; Srivastava, S; Vladykovskaya, E | 1 |
| Aldini, G; Carini, M; Orioli, M | 1 |
| Chikazawa, M; Furuhata, A; Honda, K; Kawai, Y; Shibata, N; Shibata, T; Uchida, K | 1 |
| Igarashi, K; Ishii, I; Kitada, M; Nakazato, Y; Saiki, R; Watanabe, K | 1 |
| Fu, X; Green, PS; Heinecke, JW; McDonald, TO; O'Brien, KD; Oram, JF; Shao, B; Uchida, K | 1 |
| Elbaz, M; Escargueil-Blanc, I; Negre-Salvayre, A; Salvayre, R; Uchida, K; Vindis, C | 1 |
| Freeman, MR; Kim, J; Misonou, Y; Park, YS; Takahashi, M; Takamiya, R; Taniguchi, N | 1 |
| Go, YM; Halvey, PJ; Hansen, JM; Jones, DP; Pohl, J; Reed, M | 1 |
| Park, YS; Taniguchi, N | 1 |
| Burcham, PC; Kaminskas, LM; Pyke, SM; Tan, D | 1 |
6 review(s) available for acrolein and Atherogenesis
| Article | Year |
|---|---|
Functional roles of polyamines and their metabolite acrolein in eukaryotic cells.
Topics: Acrolein; Animals; Atherosclerosis; Brain Infarction; C-Reactive Protein; Dementia; Eukaryotic Cells; Eukaryotic Translation Initiation Factor 5A; Humans; Interleukin-6; Peptide Initiation Factors; Polyamines; Protein Biosynthesis; Proteins; RNA-Binding Proteins; Sjogren's Syndrome | 2021 |
Acrolein, an environmental toxicant and its applications to in vivo and in vitro atherosclerosis models: An update.
Topics: Acrolein; Aldehydes; Atherosclerosis; Cardiovascular Diseases; Environmental Pollutants; Hazardous Substances; Humans | 2022 |
[The impact of electronic cigarettes usage on the endothelial function and the progression of atherosclerosis].
Topics: Acrolein; Atherosclerosis; Electronic Nicotine Delivery Systems; Endothelium; Formaldehyde; Humans; Nicotine; Smoking | 2018 |
Mechanisms behind the atherothrombotic effects of acrolein, a review.
Topics: Acrolein; Atherosclerosis; Dyslipidemias; Environmental Exposure; Enzyme Activation; Extracellular Matrix; Humans; Inflammation; Matrix Metalloproteinases; Plaque, Atherosclerotic; Thrombosis; Toxicokinetics | 2019 |
Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents.
Topics: Acrolein; Aldehydes; Amino Acid Sequence; Atherosclerosis; Drug Design; Humans; Molecular Sequence Data; Neurodegenerative Diseases; Proteins | 2011 |
Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury.
Topics: Acrolein; Alzheimer Disease; Animals; Atherosclerosis; Cell Death; Free Radical Scavengers; Humans; Hydralazine; Liver Diseases, Alcoholic; Oxidative Stress; Protective Agents; Spinal Cord Injuries | 2008 |
16 other study(ies) available for acrolein and Atherogenesis
| Article | Year |
|---|---|
Cinnamaldehyde Mitigates Atherosclerosis Induced by High-Fat Diet
Topics: Acrolein; Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Cholesterol, LDL; Creatine Kinase; Diet, High-Fat; Hyperlipidemias; Inflammation; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Acrolein-induced atherogenesis by stimulation of hepatic flavin containing monooxygenase 3 and a protection from hydroxytyrosol.
Topics: Acrolein; Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; Biological Transport; Cholesterol; Endothelial Cells; Humans; Inflammation; Lipid Metabolism; Lipoproteins, LDL; Liver; Mice; Oxygenases; Phenylethyl Alcohol; RAW 264.7 Cells; Signal Transduction | 2018 |
Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits.
Topics: Acrolein; Animals; Aorta; Atherosclerosis; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, Dietary; Gene Expression Regulation; Hypercholesterolemia; Male; Nitric Oxide; Peroxidase; Protective Agents; Rabbits; Triglycerides | 2018 |
Temporal and spatial changes of peroxiredoxin 2 levels in aortic media at very early stages of atherosclerotic lesion formation in apoE-knockout mice.
Topics: Acrolein; Actins; Animals; Aorta; Atherosclerosis; Cell Dedifferentiation; Gene Expression Regulation; Humans; Hydrogen Peroxide; Macrophages; Mice; Mice, Knockout, ApoE; Microfilament Proteins; Muscle Proteins; Myocytes, Smooth Muscle; Oxidative Stress; Peroxiredoxins | 2019 |
Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE
Topics: Acrolein; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cinnamomum aromaticum; Cytokines; Diet, High-Fat; Disease Models, Animal; I-kappa B Proteins; Male; Malondialdehyde; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Phosphorylation; Plant Extracts; Plaque, Atherosclerotic; Signal Transduction; Transcription Factor RelA | 2019 |
Clock-Bmal1 mediates MMP9 induction in acrolein-promoted atherosclerosis associated with gut microbiota regulation.
Topics: Acrolein; Adult; Animals; Apolipoproteins E; ARNTL Transcription Factors; Atherosclerosis; Cell Line; Circadian Clocks; Circadian Rhythm; CLOCK Proteins; Diet, High-Fat; Down-Regulation; Female; Gastrointestinal Microbiome; Human Umbilical Vein Endothelial Cells; Humans; Male; Matrix Metalloproteinase 9; Mice; Mice, Knockout | 2019 |
Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice.
Topics: Acrolein; Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Disease Models, Animal; Gastrointestinal Microbiome; Lipid Metabolism; Lythraceae; Macrophages; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Oxidative Stress; Polyphenols | 2017 |
Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages.
Topics: Acrolein; Animals; Apolipoproteins E; Atherosclerosis; Calcium; Cell Line; Environmental Pollutants; Gene Expression Regulation; Macrophages; Matrix Metalloproteinases; Mice; Mice, Knockout; Reactive Oxygen Species; Xanthine Oxidase | 2009 |
Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice.
Topics: Acrolein; Administration, Oral; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Diet; Endothelium, Vascular; Humans; Male; Mice; Mice, Knockout; Platelet Factor 4 | 2011 |
Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen.
Topics: Acrolein; Antibodies, Monoclonal; Atherosclerosis; Glutathione; Humans; Immunohistochemistry; Lipoproteins, LDL; Lysine; Oxidation-Reduction; Protein Binding; Proteins | 2012 |
Acrolein-conjugated low-density lipoprotein induces macrophage foam cell formation.
Topics: Acrolein; Apolipoproteins B; Atherosclerosis; Cell Differentiation; Cell Line, Tumor; Foam Cells; Humans; Lipoproteins, LDL; Macrophages; Scavenger Receptors, Class A | 2013 |
Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
Topics: Acrolein; Adenosine Triphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Apolipoprotein A-I; Arteries; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Blotting, Western; Cholesterol; Chromatography, Liquid; Crystallography, X-Ray; Electrophoresis, Polyacrylamide Gel; Humans; Immunohistochemistry; Inflammation; Lipid Peroxidation; Lipoproteins, HDL; Lysine; Mass Spectrometry; Models, Chemical; Molecular Sequence Data; Peptides; Peroxidase; Phospholipids; Protein Structure, Secondary; Sequence Homology, Amino Acid; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperature; Threonine; Time Factors | 2005 |
Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis.
Topics: Acrolein; Aldehydes; Animals; Atherosclerosis; Lipid Peroxidation; Lipoproteins, LDL; Muscle, Smooth, Vascular; Oxidative Stress; Phosphorylation; Receptor, Platelet-Derived Growth Factor beta | 2007 |
Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase.
Topics: Acetophenones; Acrolein; Animals; Atherosclerosis; Benzopyrans; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Induction; Humans; Imidazoles; Lung; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; Protein Kinase C-delta; Protein Kinase Inhibitors; Pyridines; RNA, Messenger; Smoking; Time Factors; Transcription, Genetic; Umbilical Veins | 2007 |
Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion.
Topics: Acrolein; Aldehydes; Amino Acid Sequence; Animals; Aorta; Atherosclerosis; Cattle; Cell Adhesion; Cell Line; Endothelial Cells; Glutathione; Humans; Inflammation; JNK Mitogen-Activated Protein Kinases; Molecular Sequence Data; Monocytes; NF-kappa B; Oxidation-Reduction; Phosphorylation; Reactive Oxygen Species; Thioredoxins | 2007 |
Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis.
Topics: Acrolein; Air Pollution; Atherosclerosis; Cyclooxygenase 2; Dinoprostone; Endothelium, Vascular; Enzyme Induction; Humans; Inflammation; Lipid Peroxidation; Polyamines; Risk Factors; Smoking; Thioredoxin-Disulfide Reductase | 2008 |